Logo
  • Real Estate
  • Personal Finance
  • Health & Wellness
  • Financials
  • DMCA
  • About Us
  • Terms of Service
  • Privacy Policy
©2021 Market Realist. All rights reserved.

Pernix Therapeutics Holdings Inc

Most Recent

  • uploads/2017/12/U.S.-Diversified-prod-1.png
    .
    Company & Industry Overviews

    Behind Valeant’s Top US Diversified Products in 3Q17

    In 3Q17, Valeant’s Wellbutrin generated revenues of $61 million, which was ~6% lower on a year-over-year basis and 5% higher quarter-over-quarter.

    By Daniel Collins3 years ago
Do Not Sell My Personal Information